(MRX) Marex Ordinary Shares - Overview
Sector: Financial Services | Industry: Capital Markets | Exchange: NASDAQ (USA) | Market Cap: 4.190m USD | Total Return: 23% in 12m
Clearing, Market Making, Derivatives, Hedging, Structured Notes
Total Rating 51
Safety 37
Buy Signal 0.90
Capital Markets
Industry Rotation: -3.2
Industry Rotation: -3.2
Market Cap:
4.19B
Avg Turnover: 44.1M
Avg Turnover: 44.1M
Risk 3d forecast
Volatility46.9%
VaR 5th Pctl7.60%
VaR vs Median-1.78%
Reward TTM
Sharpe Ratio0.62
Rel. Str. IBD85.7
Rel. Str. Peer Group87.5
Character TTM
Beta1.137
Beta Downside0.973
Hurst Exponent0.554
Drawdowns 3y
Max DD41.13%
CAGR/Max DD1.76
CAGR/Mean DD5.88
EPS (Earnings per Share)
EPS CAGR: 45.41%
EPS Trend: 86.1%
EPS Trend: 86.1%
Last SUE: 3.83
Qual. Beats: 2
Qual. Beats: 2
Revenue
Rev. CAGR: 71.65%
Rev. Trend: 48.2%
Rev. Trend: 48.2%
Last SUE: 2.84
Qual. Beats: 1
Qual. Beats: 1
Warnings
No concerns identified
Tailwinds
Supp Ema20, Leader, Tailwind, Confidence
Description: MRX Marex Ordinary Shares
Marex Group plc (MRX) is a London-based financial services platform providing liquidity, market access, and infrastructure services across global commodity and financial markets. The company operates through four primary segments: Clearing, Agency and Execution, Market Making, and Hedging and Investment Solutions. Its service suite includes execution and clearing for metals, energy, and digital assets, alongside customized OTC derivative solutions and structured notes for institutional clients.
The firm utilizes proprietary technology platforms, Neon and Agile, to deliver real-time trading, risk management, and data analytics. As an intermediary in the investment banking and brokerage sub-industry, Marex generates revenue by facilitating high-volume transactions for trading houses, banks, and producers who require hedging against price volatility in physical and financial assets. This business model relies on market volatility and trading volumes rather than traditional directional price movements.
Investors can further examine the companys valuation metrics and historical performance trends by consulting ValueRay. The platform’s integration of market data and technology infrastructure positions it as a critical liquidity provider in the global energy and agricultural sectors.
- Volatility in global commodity markets drives higher trading volumes and commission revenue
- Expansion of clearing services captures market share from traditional investment banks
- Interest rate fluctuations impact net interest income on client segregated margin balances
- Strategic acquisitions of niche brokers accelerate geographical and product line diversification
- Regulatory capital requirements influence balance sheet flexibility and dividend payout potential
Piotroski VR‑10 (Strict)
4.5
| Net Income: 453.9m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.02 > 0.02 and ΔFCF/TA -2.83 > 1.0 |
| NWC/Revenue: 336.8% < 20% (prev 51.74%; Δ 285.1% < -1%) |
| CFO/TA 0.02 > 3% & CFO 667.5m > Net Income 453.9m |
| Net Debt (-3.29b) to EBITDA (1.46b): -2.25 < 3 |
| Current Ratio: 3.16 > 1.5 & < 3 |
| Outstanding Shares: last quarter (76.1m) vs 12m ago -2.68% < -2% |
| Gross Margin: 64.77% > 18% (prev 0.43%; Δ 6.43k% > 0.5%) |
| Asset Turnover: 16.89% > 50% (prev 16.29%; Δ 0.59% > 0%) |
| Interest Coverage Ratio: 1.56 > 6 (EBITDA TTM 1.46b / Interest Expense TTM 905.6m) |
Altman Z''
3.62
| A: 0.48 (Total Current Assets 24.53b - Total Current Liabilities 7.75b) / Total Assets 34.68b |
| B: 0.03 (Retained Earnings 982.0m / Total Assets 34.68b) |
| C: 0.05 (EBIT TTM 1.42b / Avg Total Assets 29.49b) |
| D: 0.03 (Book Value of Equity 997.5m / Total Liabilities 33.41b) |
| Altman-Z'' Score: 3.62 = AA |
Beneish M
1.00
| DSRI: 0.92 (Receivables 11.07b/9.55b, Revenue 4.98b/3.96b) |
| GMI: 0.66 (GM 64.77% / 42.92%) |
| AQI: 17.45 (AQ_t 0.29 / AQ_t-1 0.02) |
| SGI: 1.26 (Revenue 4.98b / 3.96b) |
| TATA: -0.01 (NI 453.9m - CFO 667.5m) / TA 34.68b) |
| Beneish M-Score: 6.54 (Cap -4..+1) = D |
What is the price of MRX shares?
As of May 16, 2026, the stock is trading at USD 56.22 with a total of 450,485 shares traded.
Over the past week, the price has changed by -0.51%, over one month by +8.05%, over three months by +34.82% and over the past year by +22.97%.
Over the past week, the price has changed by -0.51%, over one month by +8.05%, over three months by +34.82% and over the past year by +22.97%.
Is MRX a buy, sell or hold?
Marex Ordinary Shares has received a consensus analysts rating of 4.25.
Therefore, it is recommended to buy MRX.
- StrongBuy: 3
- Buy: 4
- Hold: 1
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the MRX price?
| Analysts Target Price | 57.1 | 1.6% |
Marex Ordinary Shares (MRX) - Fundamental Data Overview
as of 15 May 2026
P/E Trailing = 13.2086 P/E Forward = 8.7642
P/S = 1.2828
P/B = 3.0137
Revenue TTM = 4.98b USD
EBIT TTM = 1.42b USD
EBITDA TTM = 1.46b USD
Long Term Debt = 2.33b USD (from longTermDebt, last quarter)
Short Term Debt = 7.75b USD (from shortTermDebt, last quarter)
Debt = 10.17b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -3.29b USD (recalculated: Debt 10.17b - CCE 13.46b)
Enterprise Value = 901.2m USD (4.19b + Debt 10.17b - CCE 13.46b)
Interest Coverage Ratio = 1.56 (Ebit TTM 1.42b / Interest Expense TTM 905.6m)
EV/FCF = 1.38x (Enterprise Value 901.2m / FCF TTM 654.4m)
FCF Yield = 72.62% (FCF TTM 654.4m / Enterprise Value 901.2m)
FCF Margin = 13.14% (FCF TTM 654.4m / Revenue TTM 4.98b)
Net Margin = 9.11% (Net Income TTM 453.9m / Revenue TTM 4.98b)
Gross Margin = 64.77% ((Revenue TTM 4.98b - Cost of Revenue TTM 1.75b) / Revenue TTM)
Gross Margin QoQ = 80.45% (prev 39.74%)
Tobins Q-Ratio = 0.03 (Enterprise Value 901.2m / Total Assets 34.68b)
Interest Expense / Debt = 7.48% (Interest Expense 760.2m / Debt 10.17b)
Taxrate = 24.94% (76.8m / 308.0m)
NOPAT = 1.06b (EBIT 1.42b * (1 - 24.94%))
Current Ratio = 3.16 (Total Current Assets 24.53b / Total Current Liabilities 7.75b)
Debt / Equity = 8.05 (Debt 10.17b / totalStockholderEquity, last quarter 1.26b)
Debt / EBITDA = -2.25 (Net Debt -3.29b / EBITDA 1.46b)
Debt / FCF = -5.03 (Net Debt -3.29b / FCF TTM 654.4m)
Total Stockholder Equity = 1.15b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.54% (Net Income 453.9m / Total Assets 34.68b)
RoE = 39.46% (Net Income TTM 453.9m / Total Stockholder Equity 1.15b)
RoCE = 40.70% (EBIT 1.42b / Capital Employed (Equity 1.15b + L.T.Debt 2.33b))
RoIC = 11.30% (NOPAT 1.06b / Invested Capital 9.40b)
WACC = 6.89% (E(4.19b)/V(14.36b) * Re(9.98%) + D(10.17b)/V(14.36b) * Rd(7.48%) * (1-Tc(0.25)))
Discount Rate = 9.98% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 15.91 | Cagr: 0.74%
[DCF] Terminal Value 76.11% ; FCFF base≈851.8m ; Y1≈559.2m ; Y5≈255.7m
[DCF] Fair Price = 134.5 (EV 6.38b - Net Debt -3.29b = Equity 9.67b / Shares 71.9m; r=6.89% [WACC]; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: 86.10 | EPS CAGR: 45.41% | SUE: 3.83 | # QB: 2
Revenue Correlation: 48.16 | Revenue CAGR: 71.65% | SUE: 2.84 | # QB: 1
EPS current Quarter (2026-06-30): EPS=1.24 | Chg30d=+8.02% | Revisions=+33% | Analysts=7
EPS next Quarter (2026-09-30): EPS=1.21 | Chg30d=+5.33% | Revisions=+11% | Analysts=7
EPS current Year (2026-12-31): EPS=5.19 | Chg30d=+9.44% | Revisions=+33% | GrowthEPS=+30.2% | GrowthRev=+24.9%
EPS next Year (2027-12-31): EPS=5.52 | Chg30d=+3.93% | Revisions=+56% | GrowthEPS=+6.2% | GrowthRev=+4.6%
[Analyst] Revisions Ratio: +56%